Last reviewed · How we verify
Tacrolimus with Methotrexate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Tacrolimus with Methotrexate (Tacrolimus with Methotrexate) — Chong Kun Dang Pharmaceutical.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tacrolimus with Methotrexate TARGET | Tacrolimus with Methotrexate | Chong Kun Dang Pharmaceutical | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tacrolimus with Methotrexate CI watch — RSS
- Tacrolimus with Methotrexate CI watch — Atom
- Tacrolimus with Methotrexate CI watch — JSON
- Tacrolimus with Methotrexate alone — RSS
Cite this brief
Drug Landscape (2026). Tacrolimus with Methotrexate — Competitive Intelligence Brief. https://druglandscape.com/ci/tacrolimus-with-methotrexate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing